Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Nov 18, 2021 4:41am
426 Views
Post# 34139474

Mixed Signals !!!

Mixed Signals !!!No disrepect .. you start with a post of your assunptions of expectations .. is that supppse to be more reassuring then your other 2 post...you think phase 1 by the end of Dec or b4 if not Jan 2022 ...why wouldnt you cover all the months because thats the stuff that comes back to bite you in the azz.....Did Rob tell you this cause I don't see a public nr.....its all just blah blah blah thats a whisper down 5 ears ....hey there was no abundance of great nr that followed the rs or any other promises that came thru via yourself... whoever posted about April start indicated it came from your site...thats why investors are getting annoyed and turning on mgmt and each other...we are wanting a public nr from the company ...they are getting mixed messages... they got caught up in the first round of assumptions and false promises that were put forth nothing happened... you bring a post telling people invested over 3yrs they are insecure investors that Rob doesn't have time to talk nor money to waste on them in nr and to sell their shares and move on...yet it sounds like Rob only has time for 1 or 2 investors and not enough time or money to spend on all the investors into his company to keep interest.... the petition whos idea...last time Rob put in nr that delay was at the sec end and a bunch of us emailed in remember ...so why isnt there a nr this time ... unfortunately your post incriminate Rob to look like schmuck ...sad thing is maybe Rob is really working on something of value for all the investors ...but the mixed messages you bring and calling investors insecure are making Rob look questionable... you nor anyone know anything unless told by Rob ...which made me question the GVHD ... the post about calling long term investors insecure really says alot about where you brought it from....that post you should have left on fb not drag it here with arrogance...glta
<< Previous
Bullboard Posts
Next >>